Physiotherapy Intervention in Climacteric Women With Dyspareunia

October 4, 2016 updated by: Hospital de Clinicas de Porto Alegre

Physiotherapy Intervention in Climacteric Women With Dyspareunia: A Randomized Controlled Trial

Aim: To evaluate the effectiveness of physical therapy intervention techniques in the improvement of dyspareunia in climacteric women.

Study design: This is a randomized controlled trial.

Study Overview

Detailed Description

Search location: Menopause and Sexuality Clinic of the department of obstetrics and Gynecology and Clinical Research Center, Hospital de Clínicas de Porto Alegre (HCPA).

Patients or participants: The recruited patients may not be vaginal atrophy (cytology-hormone test) and must provide the diagnosis of dyspareunia for more than six months being confirmed by one of the investigators through the pain score above grade 3 (visual analog pain scale) visual inspection, palpation and a questionnaire about the duration and location of pain.

Intervention and measures: consist of evaluation of the pelvic floor muscles (Oxford Scale and Perfect), myoelectric assessment (Electromyography), quality of life (Cervantes Scale), sexual function (FSFI), level of depression (Beck Scale) and pain (visual analog pain scale) before and after physical therapy intervention.

Expected results: To estimate the effectiveness of pelvic floor training techniques with physical therapy in women with dyspareunia.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • RS
      • Porto Alegre, RS, Brazil, 900035-903
        • Clinical Research Center of HCPA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • dyspareunia complaint for at least six months
  • visual analog scale of pain above 3
  • trophic vagina

Exclusion Criteria:

  • vaginal atrophy
  • neurological disorders
  • lack of cognition and understanding
  • urinary tract infection and / or genital infections
  • prolapse grade 2 and 3
  • severe systemic disease
  • performing physical therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pelvic Floor Muscle Training

superficial heat pelvic floor muscle intra vaginal manual therapy. PERFECT scale is applied in 5 sessions and based on the result of each assessment is performed the treatment plan with exercises of the pelvic floor muscles.

It is performed manual therapy in iliopsoas, diaphragm and piriformis. From the fourth session, initiate treatment with electromyographic biofeedback based on the result of PERFECT scale.

Superficial heat application in the pelvic floor muscle
Pelvic floor muscle training exercises
Manual therapy in iliopsoas, diaphragm and piriformis for 10 minutes
Intra Vaginal Manual therapy in the pelvic floor muscles
Electromyographic biofeedback in the pelvic floor muscles
Placebo Comparator: Low back
superficial heat low back Manual therapy in piriform, lumbar, iliopsoas and diaphragm.
Manual therapy in iliopsoas, diaphragm and piriformis for 10 minutes
Superficial heat application in the low back

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To evaluate the effectiveness of physiotherapy techniques in pain improvement using visual analog scale pain
Time Frame: Seven meetings, twice a week, in which the first is the initial assessment and the seventh is the final evaluation totaling a maximum of one month treatment for each patient.
To evaluate the effectiveness of physiotherapy techniques using the analog pain scale.
Seven meetings, twice a week, in which the first is the initial assessment and the seventh is the final evaluation totaling a maximum of one month treatment for each patient.

Secondary Outcome Measures

Outcome Measure
Time Frame
To evaluate the quality of life
Time Frame: To evaluate the quality of life, using Cervantes Scale in climateric women in baseline and after four weeks of intervention
To evaluate the quality of life, using Cervantes Scale in climateric women in baseline and after four weeks of intervention
To evaluate depression
Time Frame: To evaluate depression, using Beck Scale, in baseline and after four weeks of intervention
To evaluate depression, using Beck Scale, in baseline and after four weeks of intervention
To evaluate sexual function
Time Frame: To evaluate sexual function, using Female Sexual Function Index, in baseline and after four weeks of intervention
To evaluate sexual function, using Female Sexual Function Index, in baseline and after four weeks of intervention
To evaluate electrical activity of the pelvic floor muscles
Time Frame: To evaluate electrical activity of the pelvic floor muscles, using Electromyographic biofeedback , in baseline and after four weeks of intervention
To evaluate electrical activity of the pelvic floor muscles, using Electromyographic biofeedback , in baseline and after four weeks of intervention
To evaluate the pelvic floor muscle function
Time Frame: To evaluate the pelvic floor muscle function, using PERFECT Scale in baseline and after four weeks of intervention
To evaluate the pelvic floor muscle function, using PERFECT Scale in baseline and after four weeks of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria Celeste Wender, PhD, Hospital de Clinicas de Porto Alegre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2012

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

February 12, 2016

First Submitted That Met QC Criteria

June 14, 2016

First Posted (Estimate)

June 17, 2016

Study Record Updates

Last Update Posted (Estimate)

October 5, 2016

Last Update Submitted That Met QC Criteria

October 4, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dyspareunia

Clinical Trials on superficial heat pelvic floor muscle

3
Subscribe